Features Screener Stocks Charts
Sign In Sign Up

Suven Life Sciences Limited Income Statement

NSE:SUVEN | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year SUVEN income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 116.93M 66.56M
Cost of Revenue -1.14B -1.44B
Gross Profit -1.03B -1.37B
Sales, General & Admin -189.88M -208.25M
Operating Income -1.35B -1.72B
Profit Before Tax -1.06B -1.61B
Net Income -1.05B -1.61B
Diluted Shares 218.07M 218.07M
Diluted EPS -4.82 -7.37

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025